LUPUS
Clinical trials for LUPUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS trials appear
Sign up with your email to follow new studies for LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited immune cells aim to tame tough lupus
Disease control TerminatedThis study planned to test a single infusion of CB-010, a CRISPR-edited immune cell therapy, in people with severe lupus that did not respond to standard treatments. The goal was to see if it is safe and can control the disease. However, the study was withdrawn before any partici…
Matched conditions: LUPUS
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
Arthritis study tackles missed appointments with personalized help
Knowledge-focused OngoingThis study looks at whether giving people with inflammatory arthritis extra support—like a list of local resources, help from a community specialist, or a nurse navigator—can reduce missed doctor visits. About 100 adults with conditions like rheumatoid arthritis or lupus who have…
Matched conditions: LUPUS
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC